Launched at the new Arla Foods Ingredients Innovation Centre, Lacprodan BLG-100 is a pure BLG ingredient with a unique nutritional profile. Produced using a patented new separation technology, it contains 45% more leucine – the main muscle-building amino acid – than commercially available whey protein isolates.
The ingredient division of Arla Foods said the development of the new protein category presents opportunities for medical nutrition and sports nutrition manufacturers.
Consuming high-quality protein in sufficient amounts is a key nutritional need for patients and elderly people. The high leucine content of Lacprodan BLG-100 means it can support muscle protein synthesis to minimize the loss of muscle mass and sustain physical mobility.
Also, the company said it provides a more appealing taste than other commercially available proteins, which encourages compliance with nutritional regimes. It is also low in minerals, especially phosphorous, making it suitable for patients with kidney problems.
Lacprodan BLG-100 enables very high protein concentrations (as high as 23%) in very small ready-to-drink serving sizes. Its medical nutrition applications include clear ready-to-drink formats and translucent high-protein shots.
As a pure BLG, Lacprodan BLG-100 delivers all the nutritional power active consumers need. In addition to its naturally high leucine content, it provides 26% more essential amino acids (EAAs) and 40% more branched-chain amino acids than commercially available whey protein. It also offers better taste than leucine as a single amino acid.
As well as sports nutrition applications, Lacprodan BLG-100 is also suitable for clear ready-to-drink beverages and powder shakes.
Troels Nørgaard Laursen, director, health & performance nutrition at Arla Foods Ingredients, said, “BLG as a pure ingredient is a whole new protein category, and one with enormous benefits. Setting new standards for purity, Lacprodan BLG-100 has an unbeatable nutritional profile – it’s by far the most leucine-rich natural protein ingredient on the market. Not only that, but it also overcomes palatability and application issues, offering exciting opportunities in both the medical nutrition and sports nutrition sectors.”
Arla Foods Ingredients has applied for Lacprodan BLG-100 to become authorized as a novel food in the EU.
The new Arla Foods Ingredients Innovation Centre has also opened.
Dedicated to helping “discover and deliver all the wonders whey can bring to people’s lives,” the facility will develop new ingredients for food, sports nutrition, infant nutrition and medical nutrition. It will also connect scientists, technicians and industry professionals from across the world, and provide materials for clinical trials.
Based in Nr Vium in Denmark and with a total size of around 9,000m2, it will be home to 75 scientists and technicians, and includes laboratories and a pilot plant.
